People with COPD and arthritis have increased risk of death, according to study
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis ...
EurekAlert!3d
People with COPD and arthritis have an increased risk of death
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD, according to a new study.
Mirage News3d
COPD, Arthritis Linked to Higher Death Risk
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD ...
Verona Pharma: Great Year For Share Price, But Competition Threatens Bull Thesis
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
Investing22d
GSK's Nucala COPD treatment under review in China
COPD, a progressive lung condition that affects over 390 million people worldwide, is particularly prevalent in China, where nearly 100 million individuals are living with the disease. This ...
London South East22d
Nucala COPD submission accepted in China
2-4 If approved, Nucala could be the first approved biologic with monthly dosing for patients with COPD. Nucala is currently approved for use in the China across three IL-5 mediated conditions.
Pulmonology Advisor8d
In COPD, 59% of Patients Worldwide Experience Fatigue
The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...
Investing21d
GSK’s Nucala COPD treatment under review in China
COPD, a progressive lung condition that affects over 390 million people worldwide, is particularly prevalent in China, where nearly 100 million individuals are living with the disease. This represents ...